Publications by authors named "G Fournet"

Claim this Profile
I
Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors.
Raquel Pequerul, Andrada Constantinescu, Bassam Janji, Akinchan Kumar, Céline Baier, Guy Fournet

Cell Chem Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System.
Julie Carrard, Fiona Ratajczak, Joséphine Elsens, Catherine Leroy, Rebekah Kong, Guy Fournet

Biomedicines· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform.
Louise Conilh, Guy Fournet, Eric Fourmaux, Angélique Murcia, Eva-Laure Matera

Pharmaceuticals (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Rocio Rebollido-Rios, Geoffroy Venton, Sara Sánchez-Redondo, Carmela Iglesias I Felip, Guy Fournet

Oncogene· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates.
Warren Viricel, Guy Fournet, Sabine Beaumel, Emeline Perrial, Sébastien Papot

Chem Sci· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis